6 questions answered from cited research · Plain language
HIV/AIDS disproportionately affects Black people in the US due to systemic inequities including healthcare access barriers, stigma, criminalization, and underrepresentation in research and community engagement.
Read the full answer →Machine learning models can predict your CD4 and CD8 counts by analyzing patterns in your routine blood tests, organ function, and other clinical data over time, helping doctors personalize your HIV care.
Read the full answer →Yes, a once-daily bictegravir-lenacapavir single-tablet regimen is non-inferior to complex regimens for maintaining HIV-1 suppression at 48 weeks, based on phase 3 trial data.
Read the full answer →No, the number of new HIV infections among gay men in the US did not change overall from 2010 to 2019.
Read the full answer →Yes, an agricultural program called Shamba Maisha reduced food insecurity and improved psychosocial outcomes for food insecure women with HIV in Kenya, including those who became pregnant.
Read the full answer →In Uganda, about 6.4% of people with HIV on dolutegravir have viral non-suppression (viral load ≥1,000 copies/mL), based on a large routine-care cohort.
Read the full answer →